STAT3 and neoplasm: Taken together, these data suggest that tyrosine kinases engage the Y239/240-ShcA phosphorylation sites primarily to potentiate STAT3 immunosuppressive signals and use the Y313-ShcA phosphorylation sites to attenuate STAT1-dependent anti-tumour immunity.